TipRanks
Immuno-Biological Laboratories Co., Ltd. (JP:4570)
:4570
Japanese Market
4570
Immuno-Biological Laboratories Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4570 full AI Analyst Report?

Immuno-Biological Laboratories Co., Ltd. (4570) Income Statement

0 Followers

Immuno-Biological Laboratories Co., Ltd. Income Statement

Last quarter (Q1 2026), Immuno-Biological Laboratories Co., Ltd.'s total revenue was ¥286.01M, an increase of 35.24% from the same quarter last year. In Q1, Immuno-Biological Laboratories Co., Ltd.'s net income was ¥100.26M. See Immuno-Biological Laboratories Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 1.00B¥ 969.53M¥ 816.70M¥ 794.62M¥ 647.58M
Gross Profit
¥ 700.28M¥ 628.34M¥ 517.29M¥ 526.71M¥ 376.70M
Operating Expenses
¥ 419.00M¥ 419.00M¥ 412.99M¥ 468.33M¥ 498.91M
Depreciation and Amortization
¥ 18.54M¥ 15.43M¥ 2.33M¥ 0.00¥ 122.00M
EBITDA
¥ 299.82M¥ 226.55M¥ 128.11M¥ -279.54M¥ -249.50M
Operating Income
¥ 281.28M¥ 209.35M¥ 104.30M¥ 58.37M¥ -122.22M
Other Income/Expenses
¥ 19.28M¥ 515.00K¥ 20.34M¥ -338.98M¥ -127.92M
Pretax Income
¥ 300.56M¥ 209.86M¥ 124.64M¥ -280.61M¥ -250.14M
Net Income
¥ 329.01M¥ 249.05M¥ 186.69M¥ -289.73M¥ -258.77M
Per Share Metrics
Basic EPS
¥ 35.33¥ 26.74¥ 20.05¥ -31.11¥ -27.78
Diluted EPS
¥ 35.33¥ 26.74¥ 20.05¥ -31.11¥ -27.78
Weighted Average Shares Outstanding
 9.31M 9.31M 9.31M 9.31M 9.31M
Weighted Average Shares Outstanding (Diluted)
 9.31M 9.31M 9.31M 9.31M 9.31M
Currency in JPY

Immuno-Biological Laboratories Co., Ltd. Earnings and Revenue History